CN104256585A - Walnut oil-containing seal oil soft capsule - Google Patents
Walnut oil-containing seal oil soft capsule Download PDFInfo
- Publication number
- CN104256585A CN104256585A CN201410451360.3A CN201410451360A CN104256585A CN 104256585 A CN104256585 A CN 104256585A CN 201410451360 A CN201410451360 A CN 201410451360A CN 104256585 A CN104256585 A CN 104256585A
- Authority
- CN
- China
- Prior art keywords
- oil
- soft capsule
- walnut oil
- walnut
- seal oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019498 Walnut oil Nutrition 0.000 title claims abstract description 16
- 239000008170 walnut oil Substances 0.000 title claims abstract description 16
- 239000003921 oil Substances 0.000 title claims abstract description 13
- 235000019198 oils Nutrition 0.000 title claims abstract description 13
- 239000007901 soft capsule Substances 0.000 title claims abstract description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940031439 squalene Drugs 0.000 claims abstract description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 4
- 235000019197 fats Nutrition 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 210000001367 artery Anatomy 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010011084 Coronary artery embolism Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a walnut oil-containing seal oil soft capsule mainly comprising the effective constituents: seal oil [containing EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), DPA (docosapentaenoic acid) and squalene], walnut oil and phosphatidylcholine. Main auxiliary materials comprise water, vitamin E, glycerinum and edible animal gelatin. By utilizing the walnut oil-containing seal oil soft capsule, cholesterol and fat in blood can be effectively reduced, blood viscosity can be effectively reduced, blood vessel can be effectively softened and expanded, diseases of artery blood vessel induration, thrombus, and the like can be effectively prevented, and the walnut oil-containing seal oil soft capsule has the effects of nourishing brain, improving memory and preventing hypertensive disease.
Description
(1) technical field
The present invention relates to a kind of soft capsule of fur seal, especially a kind of soft capsule of fur seal containing walnut oil, belongs to technical field of health care food.
(2) background technology
At present, along with improving constantly of living standard, the intake of people to higher fatty acid meat product constantly increases, incident is the continuous rising of Blood Cholesterol and fat content, and the diseases such as the sclerosis of the heart caused thus, cerebral artery vessel, thrombus, coronary heart disease and hypertension affect and endanger the health of the elderly day by day.In order to prevent and reduce the generation of this type of disease, people start more edible fur seal oils health foods, in order to reduce cholesterol in blood and fat content.Because various fur seal oils health food ubiquity functional component existing on market is simple, effect becomes the irrational shortcoming of content ratio, the function singleness of product, DeGrain, be difficult to play desirable prevent disease and health-care effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, provide a kind of soft capsule of fur seal containing walnut oil, principle active component is: seal oil [containing EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene], lecithin, walnut oil, major auxiliary burden is water, vitamin E, glycerine and edible animal gelatin.
EPA in seal oil: be commonly called as " blood vessel street cleaner ", can reduce blood fat and cholesterol level, suppresses platelet aggregation, has and prevent vascular sclerosis, cardiovascular and cerebrovascular embolism, reduce hypertensive effect.Coronary sclerosis and embolism can be prevented, headstroke, cerebral hemorrhage, cerebrovascular disorder, high cholesterol, high fat of blood, hypertension, hand and foot numbness, the various cardiovascular and cerebrovascular disease such as palpitaition.DHA: be commonly called as " docosapentaenoic acid " is brain tissue and optic nerve development and the necessary nutriment of Function.Can be used for strengthening memory, promote infant's intellectual development and improve IQ, prevention and therapy senile dementia.DPA: the immunity that can improve human body, to diabetes, rheumatoid arthritis, psoriasis, asthma, exedens colo-enteritis etc. all have therapeutic action.Squalene: natural, contribute to anti-cancer and anticancer, and energy skin care make it smooth and full of elasticity.
Walnut oil contains a large amount of unrighted acid and has nutrition brain, reduces cholesterol and blood fat, prevents arteriosclerotic effect.Lecithin has nutrition brain prevention softening blood vessel and slows down the effect be losing one's memory.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA, DPA) not oxidized, extends shelf life of products.
The invention has the beneficial effects as follows, this soft capsule of fur seal not only can reduce cholesterol in blood and fat content, reduction blood viscosity effectively, soften and hemangiectasis, the generation of the diseases such as prevention of arterial vascular sclerosis, thrombus, but also the pathogenetic effect of nutritious brain, Improving memory, preventing hypertension.
(4) detailed description of the invention
1, content is prepared: by raw material seal oil, walnut oil is oily, vitamin E is admixed together according to certain formula, stir, the mass percent of capsule 's content functional component net content be 10 ~ 15% EPA, 20 ~ 25% DHA, 10 ~ 15% DPA, 4 ~ 8% squalene, the lecithin of 5 ~ 6%, the walnut oil of 2 ~ 3% and 1% vitamin E, all the other are other the non-functional component in seal oil.
2, capsule body material is made: with edible gelatin, glycerine and pure water for utricule raw material, glycerine and pure water are proportionally injected in glue pot, heating is stirred to about 75 DEG C, then adds gelatin, continue stirring final vacuum deaeration in 20 ~ 30 minutes, make and obtain envelop materials.
3, by the content prepared and capsule body through pelleting, shaping, wash ball, drying, make finished product soft capsule of fur seal.
Claims (2)
1., containing the soft capsule of fur seal of walnut oil, it is characterized in that: the mass percent of capsule contents raw material be seal oil [containing EPA(eicosapentaenoic acid), DHA(DHA), DPA(clupanodonic acid), squalene]: 90 ~ 92%, walnut oil: 2 ~ 3%, lecithin 5 ~ 6%, vitamin E: 1%.
2. the soft capsule of fur seal according to claim 1 containing walnut oil, it is characterized in that: the mass percent of capsule 's content functional component is: EPA:10 ~ 15%, DHA:20 ~ 25%, DPA:10 ~ 15%, squalene 4 ~ 8%, walnut oil: 2 ~ 3%, lecithin 5 ~ 6%, all the other be 1% vitamin E (antioxidant) and seal oil in other non-functional component.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451360.3A CN104256585A (en) | 2014-09-07 | 2014-09-07 | Walnut oil-containing seal oil soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451360.3A CN104256585A (en) | 2014-09-07 | 2014-09-07 | Walnut oil-containing seal oil soft capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104256585A true CN104256585A (en) | 2015-01-07 |
Family
ID=52148270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410451360.3A Pending CN104256585A (en) | 2014-09-07 | 2014-09-07 | Walnut oil-containing seal oil soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104256585A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| CN1919233A (en) * | 2006-08-29 | 2007-02-28 | 李富民 | Nourishing and health care capsule with intelligence development and memory improvement function and method for making same |
| CN103989181A (en) * | 2014-05-09 | 2014-08-20 | 宁波市成大机械研究所 | Walnut oil-containing fish oil soft capsule |
-
2014
- 2014-09-07 CN CN201410451360.3A patent/CN104256585A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (en) * | 2003-01-21 | 2004-08-11 | 刘 威 | Soft capsule of fur seal and application in preparing health products for regulating blood fat |
| CN1919233A (en) * | 2006-08-29 | 2007-02-28 | 李富民 | Nourishing and health care capsule with intelligence development and memory improvement function and method for making same |
| CN103989181A (en) * | 2014-05-09 | 2014-08-20 | 宁波市成大机械研究所 | Walnut oil-containing fish oil soft capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919383A (en) | Blend oil containing peony seed oil and preparation method of blend oil | |
| CN102232429A (en) | Novel health care oil | |
| CN109337939B (en) | Preparation method of polyunsaturated fatty acid structure lipid | |
| CN101843336A (en) | Linseed oil fat emulsion oral solution, beverage and manufacturing method thereof | |
| CN103190619A (en) | Fish oil and linseed oil soft capsules and preparation method thereof | |
| CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
| CN103082034A (en) | Health-care blend oil | |
| CN101816444A (en) | Walnut oil fat emulsion oral solution or beverage and preparation method | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN102232430A (en) | Health-care oil | |
| CN101816423A (en) | Purple perilla seed oil lipid emulsion oral solution, beverage and manufacturing method thereof | |
| CN108651635A (en) | Has effects that the nutrition-balanced health-care edible oil of brain boosting and supplementing | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| CN103651968B (en) | A kind of giant salamander purple perilla ready-mixed oil and preparation method thereof | |
| CN104187676A (en) | Seal oil soft capsule containing kudzuvine root extract | |
| CN104187727A (en) | Seal oil soft capsule containing salvia miltiorrhiza extract | |
| CN104256585A (en) | Walnut oil-containing seal oil soft capsule | |
| CN104187728A (en) | Seal oil soft capsule containing walnut kernel extract | |
| CN104187726A (en) | Seal oil soft capsule containing dogbane extract | |
| CN104187674A (en) | Seal oil soft capsule containing ginkgo biloba extract | |
| CN104187675A (en) | Seal oil soft capsule containing ginkgo biloba oil | |
| CN103053906B (en) | Preparation method of kiwi fruit seed oil oral emulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150107 |